Matrix metalloproteinase-1 promoter genotypes and haplotypes are associated with carotid plaque presence

Clinical Biochemistry

Volumn 45, Issue 16-17, 2012, Pages 1353-1356

  Djurić, Tamara ^a   Stojković, Ljiljana ^a   Zivković, Maja ^a   Končar, Igor ^b   Stanković, Aleksandra ^a   Djordjević, Ana ^a   Alavantić, Dragan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Carotid atherosclerosis; Haplotypes; Matrix metalloproteinase 1; Polymorphisms

Indexed keywords

INTERSTITIAL COLLAGENASE;

ADULT; ALLELE; ARTICLE; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CAROTID PLAQUE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE REPLICATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SERBIA;

ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84868300482     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.05.032     Document Type: Article

References (27)

1. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991, 5:2145-2154.
2. Nagase H., Woessner J.F. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494.
3. Kuzuya M, Iguchi A. Role of matrix metalloproteinases in vascular remodelling. J Atheroscler Thromb 10 (2003) 275-82.
4. Cleutjens J.P. The role of matrix metalloproteinases in heart disease. Cardiovasc Res 1996, 32:816-821.
5. Sukhova G.K., Schönbeck U., Rabkin E., Schoen F.J., Poole A.R., Billinghurst R.C., et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999, 99:2503-2509.
6. Katsuda S., Kaji T. Atherosclerosis and extracellular matrix. J Atheroscler Thromb 2003, 10:267.
7. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-2503.
8. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 1995, 748:501-507.
9. Nikkari S.T., O'Brien K.D., Ferguson M. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 1995, 92:1393-1398.
10. Affara M., Dunmore B.J., Sanders D.A., Johnson N., Print C.G., Charnock-Jones D.S. MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms. BMC Genomics 2011, 12:43.
11. Pearce E., Tregouet D.A., Samnegård A., Morgan A.R., Cox C., Hamsten A., et al. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 2005, 97:1070.
12. Román-García P., Coto E., Reguero J.R. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population. Coron Artery Dis 2009, 20:383.
13. Ghaderian S.M., Akbarzadeh Najar R., Tabatabaei Panah A.S. Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron Artery Dis 2010, 21:330-335.
14. Ye S., Gale C.R., Martyn C.N. Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur Heart J 2003, 24:1668.
15. Ghilardi G., Biondi M.L., DeMonti M., Turri O., Guagnellini E., Scorza R. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 2002, 33:2408-2412.
16. Armstrong C., Abilleira S., Sitzer M., Markus H.S., Bevan S. Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness. Stroke 2007, 38:2895-2899.
17. Han Y., Wu Z., Zhang X., Yan C., Xi S., Yang Y., et al. Impact of matrix metalloproteinase-1 gene variations on risk of acute coronary syndrome. Coron Artery Dis 2008, 19:227.
18. Dupont W.D., Plummer W.D. Power and sample size calculations: a review and computer program. Control Clin Trials 1990, 11:116-128.
19. Menashe I., Rosenberg P.S., Chen B.E. PGA, power calculator for case-control genetic association analyses. BMC Genet 2008, 9:36.
20. North American Symptomatic Carotid Endarterectomy Trial Collaborators Beneficial effect of carotid endarterectomy in symptomatic patients with highgrade carotid stenosis. N Engl J Med 1991, 325:445-453.
21. Marshall O.J. PerlPrimer, cross-platform, graphical primers design for standard, bisulphite and real-time PCR. Bioinformatics 2004, 20:2471-2472.
22. Carter K.W., McCaskie P.A., Palmer L.J. JLIN: a java based linkage disequilibrium plotter. BMC Bioinformatics 2006, 7:60.
23. Tregouet D.A., Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007, 23:1038-1039.
24. Rutter J.L., Mitchell T.I., Butticè G., Meyers J., Gusella J.F., Ozelius L.J., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998, 58:5321.
25. Wu Y.W., Yang W.S., Chen M.F. High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis. J Formos Med Assoc 2008, 107:93-98.
26. Dollery C.M., Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res 2006, 69:625-635.
27. Martin T.N., Penney D.E., Smith J.A., Groenning B.A., Dargie H.J., Hillis G.S. Matrix metalloproteinase-1 promoter polymorphisms and changes in left ventricular volume following acute myocardial infarction. Am J Cardiol 2004, 94:1044-1046.